Details of the Drug Pharmacogenomic Perturbation Atlas
General Information of Drug (ID: DMQM2JL)
| Drug Name | ||||||
|---|---|---|---|---|---|---|
| Synonyms |
Kaishi; AC1L3YXT; Prestwick0_001018; Prestwick1_001018; CBiol_001943; KBioSS_000208; KBioGR_000208; SPBio_003046; SCHEMBL2962928; KBio2_005344; CHEBI:92915; KBio3_000416; KBio2_002776; KBio3_000415; KBio2_000208; GMVPRGQOIOIIMI-DODZYUBVSA-N; Bio2_000688; Bio1_001207; Bio1_000718; Bio1_000229; Bio2_000208; AKOS032960372; DB00770; API0001428; BRD-K48099440-001-01-7
| |||||
| Cross-matching ID | ||||||
Consensus Signature of Drug Pharmacogenomic Perturbation (DPP)
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Pharmacogenomic Perturbation Across Diseases and Tissues
|
Breast
Breast adenocarcinoma
Prostate
Prostate carcinoma
|
||||||||||||||||||||||||||||||||||||||||||
